Zykadia and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Zykadia (ceritinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Tumor when taking Zykadia. It is created by eHealthMe based on reports of 2,091 people who have side effects when taking Zykadia from the FDA, and is updated regularly.

What is Zykadia?

Zykadia has active ingredients of ceritinib. eHealthMe is studying from 2,091 Zykadia users. Check the latest studies of Zykadia.

What is Tumor?

Tumor is found to be associated with 1,422 drugs and 1,704 conditions by eHealthMe. Check the latest studies of Tumor.

On Jul, 16, 2026

2,091 people reported to have side effects when taking Zykadia.
Among them, 60 people (2.87%) have Tumor.

Among these 60 people:

How long have people been on Zykadia when they have Tumor? *

What is the gender of people who have Tumor when taking Zykadia? *

female: 43.33 %
male: 56.67 %

What is the age of people who have Tumor when taking Zykadia? *

What are other drugs people take besides Zykadia? *

What are other side effects people have besides Tumor? *

Malignant Neoplasm Progression (cancer tumour came back): 53 people, 88.33%
Diarrhea: 4 people, 6.67%
Metastases To Central Nervous System (cancer spreads to central nervous system): 4 people, 6.67%
Weight Decreased: 2 people, 3.33%
Bone Disorder: 2 people, 3.33%
Cerebral Disorder (brain disease): 2 people, 3.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 3.33%
Fibrin D Dimer Decreased: 1 person, 1.67%
Hair Loss: 1 person, 1.67%
Gastrointestinal Perforation (hole in the digestive tract): 1 person, 1.67%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 5 people, 8.33%
High Blood Pressure: 2 people, 3.33%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 1.67%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 1 person, 1.67%
Inflammatory Myofibroblastic Tumor: 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zykadia and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zykadia:

Zykadia (2,091 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Zykadia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,422 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,704 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ceritinib (the active ingredients of Zykadia) and Zykadia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.